Alpa Laboratories Share Price
63.42+0.12 (+0.19%)
-34.31% past 1 Year
Alpa Laboratories Limited is a WHO-GMP and ISO 9001:2000 certified company located at Pigdamber about 15 kilometers from the city of Indore in Central India. The company has been manufacturing
Corporate filings & documents
Announcements
Results for the quarter ended June 2026 along with the approval of Notice of 38th Annual General Meeting
3 weeks agoResults for the quarter ended June 2026 along with the approval of Notice of 38th Annual General Meeting
3 weeks agoCLARIFICATION ON BOARD MEETING DATE WITH RESPECT TO THE EARLIER SUBMISSION
3 weeks agoCLARIFICATION ON BOARD MEETING DATE WITH RESPECT TO THE EARLIER SUBMISSION
3 weeks agoAlpa Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve 1. The Standalone and Consolidated unaudited Financial Results for the Quarter ended on 30th June 2026. 2. To approve the notice of 38th Annual General Meeting of the Company.3. Any other matters as may be decided by the board of directors
1 month agoAlpa Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve 1. The Standalone and Consolidated unaudited Financial Results for the Quarter ended on 30th June 2026. 2. To approve the notice of 38th Annual General Meeting of the Company.3. Any other matters as may be decided by the board of directors
1 month agoDisclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
1 month agoDisclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
1 month agoPursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we hereby inform you that Ms. Jyoti Jain has ceased to be an Independent Director of the company upon completion of her tenure with effect from the close of business hours on 21st july 2026.
1 month agoPursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we hereby inform you that Ms. Jyoti Jain has ceased to be an Independent Director of the company upon completion of her tenure with effect from the close of business hours on 21st july 2026.
1 month agoMs.Yashoda Patidar has resigned from the post of Company Secretary & Complaince Officer w.e.f. 26th July 2026.
1 month agoMs.Yashoda Patidar has resigned from the post of Company Secretary & Complaince Officer w.e.f. 26th July 2026.
1 month agoWe wish to inform that in pursuant of Securities and Exchange Board of India (Prohibition of Insider Trading)(Amendment) Regulation 2018 and Companys Code of Conduct for Regulating Monitoring and Reporting of Trading Window for dealing in Securities / Shares of the Company shall remain closed with effect from 1st July 2026 till 48 hours after the declaration of the Financial Results by the Company for the First Quater ending June 30 2026.
2 months agoWe wish to inform that in pursuant of Securities and Exchange Board of India (Prohibition of Insider Trading)(Amendment) Regulation 2018 and Companys Code of Conduct for Regulating Monitoring and Reporting of Trading Window for dealing in Securities / Shares of the Company shall remain closed with effect from 1st July 2026 till 48 hours after the declaration of the Financial Results by the Company for the First Quater ending June 30 2026.
2 months agoResults for the quarter and year ended March 2026
3 months agoAlpa Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve Audited Standalone & Consolidated Financial Results of the Company for the Quarter and Financial year ended on 31st March 2026.
3 months agoAlpa Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve Audited Standalone & Consolidated Financial Results of the Company for the Quarter and Financial year ended on 31st March 2026.
3 months agoAppointment of Ms.Yashoda Patidar as the Company Secretary and Complaince Officer of the company w.e.f. April 11 2026.
4 months agoAppointment of Ms.Yashoda Patidar as the Company Secretary and Complaince Officer of the company w.e.f. April 11 2026.
4 months agoClarification on the Price Sensitive Information via email dt8th April 2026
4 months agoClarification on the Price Sensitive Information via email dt8th April 2026
4 months agoThe Exchange has sought clarification from Alpa Laboratories Ltd on April 8 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
4 months agoThe Exchange has sought clarification from Alpa Laboratories Ltd on April 8 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
4 months agoThe trading Window of the company shall remain closed w.e.f 01st April 2026 till 48 hours after the declaration of the Financial results by the company for the fourth quarter and financial year ending 31st March 2026.
5 months agoThe trading Window of the company shall remain closed w.e.f 01st April 2026 till 48 hours after the declaration of the Financial results by the company for the fourth quarter and financial year ending 31st March 2026.
5 months agoThe Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Vinit Shah
5 months agoThe Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Vinit Shah
5 months agoThe Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Vinit Shah
5 months agoThe Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Vinit Shah
5 months agoMs Srashti Chopra has resigned from the post of Company Secreatary and Compliance Officer wef 25th March 2026.
6 months agoMs Srashti Chopra has resigned from the post of Company Secreatary and Compliance Officer wef 25th March 2026.
6 months agoFinancial Results
6 months agoAlpa Laboratories Limited has submitted to the Exchange the financial results for the period ended December 31 2025.
6 months agoAlpa Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2025
7 months agoAlpa Laboratories has informed the exchange regarding the closure of trading window pursuant to SEBI (Prohibition of Insider Trading) Regulation 2015
8 months agoFinancial Results for the quarter and half year ended September 30 2025
9 months agoAlpa Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve ALPA LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2025
10 months agoAlpa Laboratories Limited has submitted the exchange a copy of Scrutinizers Report of AGM held on September 29 2025.
11 months agoAlpa Laboratories has informed the exchange regarding outcome of Annual General Meeting held on September 29 2025.
11 months agoAlpa Laboratories has informed the exchange regarding the Closure of Trading Window pursuant to SEBI (Prohibition of Insider Trading) Regulation 2015
11 months agoAlpa Laboratories Limited has informed the exchange that Register of Members and Share Transfer Books of the Company will remain closed from 22-sep 2025 to 29-Sep 2025 for the Purpose of Annual General Meeting.
12 months agoAnnual Report along with notice of AGM for the year ended March 2025.
12 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
33/2 Pigdamber A B Road Rau Indore Dist Madhya Pradesh PIN: 453446 Tel No: 0731-4294567 Fax No: 0730-4294444 Email: [email protected] Internet: www.alpalabs.in
Registrars
Office No S6-2, 6th Floor, Pinnacle Business Park,ext to Ahura Centre, Mahakali Caves Road, Andheri (East) Mumbai - 400093(old address - Bharat Tin Works building, 1st floor, Opp. Vasant Oasis, Andheri East Mumbai - 400 059Tel: + 91 21 626 38200Fax: Office No S6-2, 6th Floor, Pinnacle Business Park Next to Ahura Centre, Mahakali Caves Road Andheri (E) PIN: Tel No: 91-022-62638200 Fax No: 91-022-62638299 Email: [email protected]
Management
Mahendra Singh Chawla, Chairman
Paresh Chawla, Managing Director
Pravin Shah, Whole Time Director
Shitul Shah, Whole Time Director
Vitthal Kothana, Whole Time Director
Sunil Valecha, Non Executive Independent Director
Sanket Baheti, Non Executive Independent Director
Pratibha Lunawat, Non Executive Independent Director
Pratik Shah, Non Executive Independent Director
Details
BSE 532878
NSE ALPA
ISIN INE385I01010